Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives

Abstract

Metal-based compounds form a promising class of therapeutic agents, whose mechanisms of action still need to be elucidated, and that are in general prone to undergo extensive speciation in physiological environment. Thus, determination of the fate of the metal compounds in complex biological systems, contributing to their overall pharmacological and toxicological profiles, is important to develop more rationalised and targeted metal-based drugs. To these aims, a number of spectroscopic and biophysical methods, as well as analytical techniques, are nowadays extensively applied to study the reactivity of metal complexes with different biomolecules (e.g. nucleic acids, proteins, buffer components). Among the various techniques, molecular mass spectrometry (MS) has emerged in the last decade as a major tool to characterise the interactions of metallodrugs at a molecular level. In this review, we present an overview of the information available on the reactivity of various families of therapeutic metallodrugs (mainly anticancer compounds based on Pt, Ru, Au and As) with biomolecules studied by different MS techniques, including high-resolution ESI-, MALDI-and ion mobility-MS among others. Representative examples on the potential of the MS approach to study non-covalent interactions are also discussed. The review is organized to present results obtained on samples with different degrees of complexity, from the interactions of metal compounds with small model nucleophiles (amino acids and nucleobases), model peptides/oligonucleotides, target proteins/nucleic acids, to the analysis of serum, cell extracts and tissue samples. The latter requiring combination of proteomic methods with advanced MS techniques. Correlations between molecular reactivity of metallodrugs and biological activity are hard to establish, but differences in the reactivity of metallodrugs to biomolecules and their different adducts, as revealed by MS methods, may indicate differences in their modes of action. Overall, the knowledge offered by MS methods on metallodrugs speciation is invaluable to establish new rules and define new trends in the periodic table aimed at rationalizing the behavior of metal compounds in complex living systems. Keywordsmetal-based drugs; proteins; nucleic acids; mass spectrometry; metallomics. Corresponding Author Angela Casini Corresponding Author's InstitutionCardiff University To view all the submission files, including those not included in the PDF, click on the manuscript title on your EVISE Homepage, then click 'Download zip file'. Order of Authors 1 Answers to Reviewers Reviewer 1 The authors have made some effort to answer suggestions and the manuscript is improved. Since it is a review, there is, strictly, no new information but nevertheless the compilation of data and references could be useful.Answer: no further comments. Liu et al." in place of "Lu et al." iv) Some symbols in the PDF file are not correctly displayed. Reviewer Answer:We have inserted all the minor modifications requested by this rev...

Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications

“…In previous sections, we have described the importance of vanadium at industrial level, the chemical speciation of binary and ternary complexes with amino acids and very briefly their importance at the biological level. The studies of chemical speciation in aqueous solution are fundamental to know the nature, abundance and stability of the different species in solution, because they represent an essential requirement to evaluate the biological activity of promising therapeutic targets [121][122][123][124][125][126]. In this section we will discuss the applications of vanadium compounds, especially vanadium complexes with (non)essential amino acids, in pharmacology and medical therapeutics, as well as their importance in bioinorganic chemistry.…”

Selective binding of an organoruthenium complex to G‐rich human telomeric sequence by tandem mass spectrometry

“…38,39 The intact DNA or its adduct ions are directly introduced into the mass spectrometer for fragmentation to yield a sufficient number of informative and regular fragment ions to obtain the primary structures of the precursor ions, in particular to identify the binding sites of metal-based anticancer complexes on DNA. [40][41][42] Top-down MS requires no change in pH nor additions of catalytic metal cations as they may interfere with the interactions of metallodrugs with DNA. 43 During CID fragmentation, oligodeoxynucleotides typically undergo loss of a nucleobase B (B is one of the nucleobases A, C, G or T), then a second elimination reaction leads to formation of a furan ring which may be followed by cleavage of the adjacent 3′-C-O phosphodiester bond of the deoxyribose to yield complementary (a -B) and w ions.…”

Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cells

“…MS techniques are nowadays applicable to several research questions, ranging from the analysis of metallodrugs in model systems to the study of their tissue distribution. 12,13 This versatility is mainly enabled by the orthogonal types of sample ionization, most commonly inductively coupled plasma (ICP) and electrospray ionization (ESI). 12 The former is preferentially employed to quantify metal isotopes in complex biological matrices, while the latter was initially used to study model systems and provides molecular information on the interaction products between metallodrugs and biomolecules.…”